Moreover, the data obtained from the disease-free interval (DFI) analysis suggested that RBMX is a protective factor in BRCA, brain lower grade glioma (LGG), READ, stomach adenocarcinoma (STAD), and THCA. The gene discussed is RBMX; the disease is gastric adenocarcinoma.